Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Jan;77(1):35-40.
doi: 10.1016/j.humimm.2015.10.010. Epub 2015 Oct 22.

Protective effect of HLA-DQB1 alleles against alloimmunization in patients with sickle cell disease

Zohreh Tatari-Calderone  1 , Heather Gordish-Dressman  2 , Ross Fasano  3 , Michael Riggs  4 , Catherine Fortier  5 , Andrew D Campbell  6 , Dominique Charron  5 , Victor R Gordeuk  7 , Naomi L C Luban  3 , Stanislav Vukmanovic  8 , Ryad Tamouza  9
Affiliations

Protective effect of HLA-DQB1 alleles against alloimmunization in patients with sickle cell disease

Zohreh Tatari-Calderone et al. Hum Immunol. 2016 Jan.

Erratum in

Abstract

Background: Alloimmunization or the development of alloantibodies to Red Blood Cell (RBC) antigens is considered one of the major complications after RBC transfusions in patients with sickle cell disease (SCD) and can lead to both acute and delayed hemolytic reactions. It has been suggested that polymorphisms in HLA genes, may play a role in alloimmunization. We conducted a retrospective study analyzing the influence of HLA-DRB1 and DQB1 genetic diversity on RBC-alloimmunization.

Study design: Two-hundred four multi-transfused SCD patients with and without RBC-alloimmunization were typed at low/medium resolution by PCR-SSO, using IMGT-HLA Database. HLA-DRB1 and DQB1 allele frequencies were analyzed using logistic regression models, and global p-value was calculated using multiple logistic regression.

Results: While only trends towards associations between HLA-DR diversity and alloimmunization were observed, analysis of HLA-DQ showed that HLA-DQ2 (p=0.02), -DQ3 (p=0.02) and -DQ5 (p=0.01) alleles were significantly higher in non-alloimmunized patients, likely behaving as protective alleles. In addition, multiple logistic regression analysis showed both HLA-DQ2/6 (p=0.01) and HLA-DQ5/5 (p=0.03) combinations constitute additional predictor of protective status.

Conclusion: Our data suggest that particular HLA-DQ alleles influence the clinical course of RBC transfusion in patients with SCD, which could pave the way towards predictive strategies.

Keywords: Alloimmunization; HLA-DQB1; HLA-DRB1; Red Blood Cell transfusion; Sickle cell disease.

PubMed Disclaimer

References

    1. Adams RJ, McKie VC, Hsu L, Files B, Vichinsky E, Pegelow C, et al. Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. The New England journal of medicine. 1998;339:5–11. - PubMed
    1. Adams RJ, Brambilla D. Discontinuing prophylactic transfusions used to prevent stroke in sickle cell disease. The New England journal of medicine. 2005;353:2769–78. - PubMed
    1. Russell MO, Goldberg HI, Reis L, Friedman S, Slater R, Reivich M, et al. Transfusion therapy for cerebrovascular abnormalities in sickle cell disease. The Journal of pediatrics. 1976;88:382–7. - PubMed
    1. Orlina AR, Unger PJ, Koshy M. Post-transfusion alloimmunization in patients with sickle cell disease. American journal of hematology. 1978;5:101–6. - PubMed
    1. Piomelli S. Chronic transfusions in patients with sickle cell disease. Indications and problems The American journal of pediatric hematology/oncology. 1985;7:51–5. - PubMed

Publication types

MeSH terms